Role of Corticotropin-Releasing Factor and Corticosterone in Behavioral Sensitization to Ethanol
Authors:
- Cheryl ReedCRCheryl Reed
- Paul J. MeyerPMPaul J. Meyer
- Carrie McKinnonCMCarrie McKinnon
- Andrey E. RyabininARAndrey E. Ryabinin
- Tamara J. PhillipsTamara J. Phillips
- 1 May 2012
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 341 (2) , 455-463
Abstract
Neuroadaptations underlying sensitization to drugs of abuse seem to influence compulsive drug pursuit and relapse associated with addiction. Our previous data support a role for the corticotropin-releasing factor (CRF) type-1 receptor (CRF1) in ethanol (EtOH)-induced psychomotor sensitization. CRF1 is endogenously activated by CRF and urocortin-1. Because genetic deletion of urocortin-1 did not affect EtOH sensitization, we hypothesized that CRF is the important ligand underlying EtOH sensitization. To test this hypothesis, we used heterozygous and homozygous knockout (KO) mice, which lack one or both copies of the gene coding for CRF, and their respective wild-type controls. EtOH sensitization was normal in heterozygous, but absent in homozygous, CRF KO mice. Corticosterone (CORT) levels were drastically reduced only in CRF KO mice. Because CRF/CRF1 initiate EtOH-induced activation of the hypothalamic-pituitary-adrenal axis, we investigated CORT effects on EtOH sensitization. The CORT synthesis inhibitor metyrapone prevented the acquisition, but not the expression, of EtOH sensitization. Exogenous CORT administration sensitized the locomotor response to a subsequent EtOH challenge; we observed, however, that the exogenous CORT levels necessary to induce sensitization to EtOH were significantly higher than those produced by EtOH treatment. Therefore, participation of CORT seems to be necessary, but not sufficient, to explain the role of CRF/CRF1 in the acquisition of sensitization to EtOH. Extra-hypothalamic CRF/CRF1 mechanisms are suggested to be involved in the expression of EtOH sensitization. The present results are consistent with current theories proposing a key role for CRF and CRF1 in drug-induced neuroplasticity, dependence, and addictive behavior.Keywords
This publication has 45 references indexed in Scilit:
- Corticotropin‐Releasing Factor Acting on Corticotropin‐Releasing Factor Receptor Type 1 is Critical for Binge Alcohol Drinking in MiceAlcohol, Clinical and Experimental Research, 2011
- Ethanol concentration-dependent effects and the role of stress on ethanol drinking in corticotropin-releasing factor type 1 and double type 1 and 2 receptor knockout micePsychopharmacology, 2011
- Dynamics of Neuronal Circuits in Addiction: Reward, Antireward, and Emotional MemoryPharmacopsychiatry, 2009
- Role of Various Neurotransmitters in Mediating the Long‐Term Endocrine Consequences of Prenatal Alcohol ExposureAnnals of the New York Academy of Sciences, 2008
- The incentive sensitization theory of addiction: some current issuesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addictionPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: A urocortin1-independent mechanismProceedings of the National Academy of Sciences, 2008
- Corticotropin releasing factor-1 receptor antagonist, CP-154,526, blocks the expression of ethanol-induced behavioral sensitization in DBA/2J miceNeuroscience, 2007
- A key role for corticotropin-releasing factor in alcohol dependenceTrends in Neurosciences, 2007
- The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditionsPsychoneuroendocrinology, 2004